Clinical and economic impact of exercise electrocardiography and exercise echocardiography in clinical practice

European Heart Journal

Volumn 24, Issue 12, 2003, Pages 1153-1163

  Marwick, T H ^a   Shaw, L ^b   Case, C ^a   Vasey, C ^c   Thomas, J D ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b EMORY UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d Asheville Cardiology Associates   (United States)

Author keywords

Coronary artery disease; Cost effectiveness; Exercise echocardiography; Exercise electrocardiography; Risk

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; IMAGE ANALYSIS; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE; TECHNIQUE; TRANSLUMINAL CORONARY ANGIOPLASTY;

CORONARY ARTERIOSCLEROSIS; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT;

EID: 0037937371     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(03)00113-1     Document Type: Article

References (35)

1. Hachamovitch R, Berman DS, Shaw LJ et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.
2. Marwick TH, Case C, Vasey C et al. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation 2001;103:2566-71.
3. Gibbons RJ, Balady GJ, Beasley JW et al. ACC/AHA Guidelines for Exercise Testing. J Am Coll Cardiol 1997;30:260-311.
4. Shaw LJ, Mulvagh SL, Jacobson C et al. Cost implications of diagnosing coronary disease. Eur Heart J 2000;21:477.
5. Shaw LJ, Peterson ED, Shaw LK et al. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circulation 1998;98:1622-30.
6. Feigenbaum H. Exercise echocardiography. J Am Soc Echo 1988;1:161-6.
7. Foster E, Cahalan MK. The search for intelligent quantitation in echocardiography: 'eyeball', 'trackball' and beyond. J Am Coll Cardiol 1993;22:848-50.
8. Hoffmann R, Lethen H, Marwick T et al. Standardized guidelines for the interpretation of dobutamine echocardiography reduce interinstitutional variance in interpretation. Am J Cardiol 1998;82:1520-4.
9. Bach DS, Muller DW, Gros BJ et al. False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings. J Am Coll Cardiol 1994;24:928-33.
10. Shaw LJ, Hachamovitch R, Heller GV et al. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. Am J Cardiol 2000;86:1-7.
11. Pryor DB, Shaw L, McCants CB et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993;118:81-90.
12. Shaw LJ, Hachamovitch R, Berman DS et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol 1999;33:661-9.
13. Garber AM. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999;20:157.
14. Kuntz KM, Fleischmann KE, Hunink MG et al. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med 1999;130:709-18.
15. Weintraub WS, Maildin PD, Becker E et al. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel CAD. Results from the Emory Angioplasty Surgery Trial (EAST). Circulation 1995;92:28-31.
16. Weintraub WS, Mahoney EM, Ghazzal ZM et al. Trends in outcome and costs of coronary intervention in the 1990s. Am J Cardiol 2001;88:497-503.
17. Cohen DJ, Becker ER, Cutter SD et al. Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratories. Am J Cardiol 2000;86:595-601.
18. Russell MW, Huse DM, Drowns S et al. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998;81:1110-5.
19. Patterson RE, Eisner RL, Horowitz SF. Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 1995;91:54-65.
20. Marwick TH, Anderson T, Williams MJ et al. Exercise echocardiography is an accurate and cost-efficient technique for the detection of coronary artery disease in women. J Am Coll Cardiol 1995;26:335-41.
21. Marwick TH, Torelli J, Harjai K et al. Influence of left ventricular hypertrophy on detection of coronary artery disease using exercise echocardiography. J Am Coll Cardiol 1995;26:1180-6.
22. Alderman EL, Fisher LD, Litwin P et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
23. Mock MB, Ringqvist I, Fisher LD et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982;66:562-8.
24. Gibson RS, Watson DD, Craddock GB et al. Prediction of cardiac events after uncomplicated myocardial infarction: A prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983;68:321-36.
25. Marwick TH, Case C, Sawada S et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol 2001;37:754-60.
26. Weiner DA, Ryan TJ, Parsons L et al. Long-term prognostic value of exercise testing in men and women from the Coronary Artery Surgery Study (CASS) registry. Am J Cardiol 1995;75:865-70.
27. Jones RH, Johnson SH, Bigelow C et al. Exercise radionuclide angiocardiography predicts cardiac death in patients with coronary artery disease. Circulation 1991;84:52-8.
28. Berman DS, Hachamovitch R, Kiat H et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1990;26:639-47.
29. Hachamovitch R, Berman DS, Kiat H et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
30. Pingitore A, Picano E, Varga A et al. Prognostic value of pharmacological exercise echocardiography in patients with known or suspected coronary artery disease. J Am Coll Cardiol 1999;34:1769-77.
31. O'Keefe JH, Bateman TM, Ligon RW et al. Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease. J Nucl Cardiol 1998;5:28-33.
32. Bateman TM, O'Keefe JH, Dong VM et al. Coronary angiographic rates after stress single-photon emission computed tomographic scintigraphy. J Nucl Cardiol 1995;2:217-23.
33. Fleischmann KE, Hunink MG, Kuntz KM et al. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998;280:913-20.
34. Kwok Y, Kim C, Grady D et al. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-6.
35. Underwood SR, Godman B, Satyani S et al. Economics of myocardial perfusion imaging in Europe-the EMPIRE Study. Eur Heart J 1999;20:157-66.